Literature DB >> 17852192

Increase in Fe3+/Fe2+ ratio and iron-induced oxidative stress in Eales disease and presence of ferrous iron in circulating transferrin.

Radhakrishnan Selvi1, Narayanasamy Angayarkanni, Muthuvel Bharathselvi, Ramakrishnan Sivaramakrishna, Thomas Anisha, Biswas Jyotirmoy, Badrinath Vasanthi.   

Abstract

Eales disease was shown to be associated with oxidant stress and weak antioxidant defense. Total iron, ferrous iron, thiobarbituric acid reactive substances (TBARS), and ceruloplasmin were estimated in the blood samples of patients with inflammation, perivasculitis, and venous insufficiency. Levels of ferric iron were determined from the difference in those of total iron and ferrous iron. All biochemical parameters were estimated in age and sex-matched controls. Fe3+/Fe2+ ratio was greater in patients with Eales disease than in normal controls. Similar increase in TBARS and ceruloplasmin levels were noted. The patients were treated with prednisone and vitamins E and C, then Fe3+/Fe2+ ratios and TBARS decreased progressively; the active state of the disease was reduced to 16%. So Fe3+/Fe2+ ratio in addition to TBARS levels could be considered an index of the active state of the disease. Circulating transferrin in blood did contain ferrous iron. Binding of ferrous iron to transferrin was confirmed by estimating iron-binding capacity using ferrous ammonium sulphate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852192     DOI: 10.1080/02713680701486402

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Total antioxidant capacity in Eales' disease, uveitis & cataract.

Authors:  Radhakrishnan Selvi; Narayanasamy Angayarkanni; Jyotirmay Biswas; Sivaramakrishnan Ramakrishnan
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

2.  Eales' disease - current concepts in diagnosis and management.

Authors:  Jyotirmay Biswas; Reesha Karingattil Ravi; Angayarkanni Naryanasamy; Lily Therese Kulandai; Hajib Naraharirao Madhavan
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.